Healthcare Mar 24, 2021 05:40 PM (GMT+8) · EqualOcean
The Shanghai Cell Therapy Group has raised CNY 500 million in a funding round which is jointly made by Jiuzhou Venture, Haier Capital, and CCB International. The capital will be used for further product research and development. The company is a cellular diagnostic center provider combining cellular research and treatment services. The company engages in cellular cold storage, cellular pharmaceuticals, antibody research. According to the Fiormarkets Report, the global cell therapy technology market exceeds USD 34 billion by 2025. This briefing is contributed by and first appeared on CIMK.

Source: CIMK